EUVIMEDEUVIMED entdecken
Crossref

Transmucosal delivery of a dendritic cell-targeting intranasal nanovaccine boosts HIV-1 specific mucosal and systemic immune responses

Yaotian Chang, Xiaoqian Xin, Tongshuai Wang, Xiaopan Liu, Qingyu Wang, Yuhua Shi, Yaming Shan

Acta Biomaterialia · 2026-03 · 213 · 594-608

DOI: 10.1016/j.actbio.2026.02.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-03. Verfasst von Yaotian Chang und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, Jilin 130012, PR China. Hauptthemen laut MEDLINE: Dendritic Cells, Nanovaccines, Immunity, Mucosal, HIV-1. Die Arbeit nennt 60 Literaturangaben. Gefördert von: Jilin Scientific and Technological Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The induction of secretory IgA (sIgA) on mucosal surfaces is crucial for developing vaccines that effectively prevent Human immunodeficiency virus type 1 (HIV-1) transmission. However, the mucosal barrier significantly limits antigen absorption, resulting in weak systemic and mucosal immune responses. In this study, a novel dual-function nanovaccine for intranasal administration of HIV-1 native-like envelope (Env) proteins was developed. Specifically, the amphiphilic polymer coating (DPPD2) was synthesized by conjugating P-D2, a peptide that targets the CD11c receptor on dendritic cells (DCs), to DSPE-PEG (DP). DPPD2 was then employed to surface-functionalize the amino-modified mesoporous silica nanoparticle (MSN) that was loaded with Env and Toll-like receptor 9 agonist CpG, resulting in a DC-targeting nanovaccine. DPPD2/Env/CpG@MSN could synergistically boost trans-mucosal penetration of Env proteins and the recruitment, antigen uptake and activation of submucosal DCs. More importantly, we found that DPPD2/Env/CpG@MSN promoted germinal center (GC) responses in the muco-associated lymphoid tissue and draining lymph nodes, further leading to significantly enhanced HIV-1-specific sIgA antibody levels in situ and distant mucosal sites. Furthermore, systemic immune responses such as serum neutralizing antibodies against heterologous HIV-1 pseudoviruses and systemic T cell immunity were improved. Our study introduces a unique functional intranasal nanovaccine, providing a basis for developing subunit vaccines against mucosal viral infections. STATEMENT OF SIGNIFICANCE: The development of effective strategies to prevent mucosal transmission of HIV-1 is crucial for combating AIDS. Current HIV-1 Env subunit vaccines have shown limited immunogenicity in mucosal immunity studies. This work developed an intranasal nanovaccine, DPPD2/Env/CpG@MSN, to synergistically enhance trans-mucosal penetration of the Env protein and its subsequent uptake by submucosal DCs. The results demonstrated that DPPD2/Env/CpG@MSN effectively boosted germinal center responses and antibody production. The levels of Env-specific sIgA antibodies were significantly elevated in both local and distant mucosal sites. Moreover, the nanovaccine also elicited robust Env-specific T cell immune responses in spleen. This design provides a promising strategy for enhancing the immunogenicity of HIV-1 subunit vaccines in mucosal vaccination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsNanovaccinesImmunity, MucosalHIV-1AIDS VaccinesAnimalsAdministration, IntranasalFemaleNanoparticlesImmunoglobulin A, SecretoryMice, Inbred BALB CProtein Subunit VaccinesMiceHumans

Stichwörter der Autor:innen

Dendritic cell-targetingEnvelopeHIV-1Mucosal immunitymesoporous silica nanoparticle (MSN)vaccine

Substanzen

NanovaccinesAIDS VaccinesImmunoglobulin A, SecretoryProtein Subunit Vaccines

Autor:innen und Institutionen

  • National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, Jilin 130012, PR China.
  • Key Laboratory of Ministry of Education for Viral Pathogenesis & Infection Prevention and Control, School of Medicine, Jinan University, Guangzhou, Guangdong 510632, PR China.
  • State Key Laboratory of Inorganic Synthesis & Preparative Chemistry, Jilin University, Changchun 130012, PR China.
  • National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, Jilin 130012, PR China; Key Laboratory for Molecular Enzymology and Engineering, the Ministry of Education, School…

Förderung

  • Jilin Scientific and Technological Development Program

Zitieren

APA

Chang, Y., Xin, X., Wang, T., Liu, X., Wang, Q., Shi, Y., & Shan, Y. (2026). Transmucosal delivery of a dendritic cell-targeting intranasal nanovaccine boosts HIV-1 specific mucosal and systemic immune responses. Acta Biomaterialia, 213, 594-608. https://doi.org/10.1016/j.actbio.2026.02.021

Vancouver

Chang Y, Xin X, Wang T, Liu X, Wang Q, Shi Y, et al. Transmucosal delivery of a dendritic cell-targeting intranasal nanovaccine boosts HIV-1 specific mucosal and systemic immune responses. Acta Biomaterialia. 2026;213:594-608. doi:10.1016/j.actbio.2026.02.021

BibTeX
@article{Chang2026,
  author = {Chang, Yaotian and Xin, Xiaoqian and Wang, Tongshuai and Liu, Xiaopan and Wang, Qingyu and Shi, Yuhua and Shan, Yaming},
  title = {Transmucosal delivery of a dendritic cell-targeting intranasal nanovaccine boosts HIV-1 specific mucosal and systemic immune responses},
  journal = {Acta Biomaterialia},
  year = {2026},
  volume = {213},
  pages = {594--608},
  doi = {10.1016/j.actbio.2026.02.021}
}
Kostenlos starten →